Hohenwallner, K., & Rampler, E. (2022). „Fatty-sweet Symphony“ der Stammzellen: Gangliosid-Code massenspektrometrisch entschlüsselt. Laborpraxis.

Hohenwallner, K., Troppmair, N., Panzenboeck, L., Kasper, C., El Abiead, Y., Koellensperger, G., Lamp, L. M., Hartler, J., Egger, D., & Rampler, E. (2022). Decoding Distinct Ganglioside Patterns of Native and Differentiated Mesenchymal Stem Cells by a Novel Glycolipidomics Profiling Strategy. JACS Au, 2(11), 2466-2480. https://doi.org/10.1021/jacsau.2c00230

Rampler, E., Pühringer, M., & Hohenwallner, K. (2022). Glycolipids at the forefront: New avenues in mass spectrometry-based glycolipidomics workflows. Wiley analytical science magazine.

Baier, D., Schönhacker-Alte, B., Rusz, M., Pirker, C., Mohr, T., Mendrina, T., Kirchhofer, D., Meier-Menches, S. M., Hohenwallner, K., Schaier, M., Rampler, E., Koellensperger, G., Heffeter, P., Keppler, B., & Berger, W. (2022). The Anticancer Ruthenium Compound BOLD-100 Targets Glycolysis and Generates a Metabolic Vulnerability towards Glucose Deprivation. Pharmaceutics, 14(2), [238]. https://doi.org/10.3390/pharmaceutics14020238

Fronik, P., Poetsch, I., Kastner, A., Mendrina, T., Hager, S., Hohenwallner, K., Schueffl, H., Herndler-Brandstetter, D., Koellensperger, G., Rampler, E., Kopecka, J., Riganti, C., Berger, W., Keppler, B. K., Heffeter, P., & Kowol, C. R. (2021). Structure-Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating Ligands. Journal of Medicinal Chemistry, 64(16), 12132-12151. https://doi.org/10.1021/acs.jmedchem.1c00770